Cotreatment with pioglitazone, a synthetic ligand for peroxisome proliferator-activated receptor γ (PPARγ), enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Induced apoptosis of human leukemia cells.

被引：0
|
作者：
Park, JI
Han, H
Han, JS
Kwon, HC
Han, JY
Jeong, JS
Bae, YS
Kwak, JY
机构：
[1] Dong A Univ, Coll Med, Dept Biochem, Pusan, South Korea
[2] Dong A Univ, Coll Med, Dept Internal Med, Pusan, South Korea
[3] Dong A Univ, Coll Med, Dept Lab Med, Pusan, South Korea
[4] Dong A Univ, Coll Med, Dept Pathol, Pusan, South Korea
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4377
引用
收藏
页码：178B / 178B
页数：1
相关论文
共 50 条
  • [21] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) during liver regeneration
    Yamaguchi, Y
    Shiraki, K
    Saitou, Y
    Nakano, T
    Mizuno, S
    Uemoto, S
    JOURNAL OF HEPATOLOGY, 2004, 40 (04) : 718 - 719
  • [22] Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
    Song, JH
    Bellail, A
    Tse, MCL
    Yong, VW
    Hao, CH
    JOURNAL OF NEUROSCIENCE, 2006, 26 (12): : 3299 - 3308
  • [23] Trifloxystrobin induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in HaCaT, human keratinocyte cells
    Jang, Yoonjeong
    Lee, Ah Young
    Chang, Seung-Hee
    Jeong, Sang-Hee
    Park, Kyung-Hun
    Paik, Min-Kyoung
    Cho, Nam-Joon
    Kim, Ji-Eun
    Cho, Myung-Haing
    DRUG AND CHEMICAL TOXICOLOGY, 2017, 40 (01) : 67 - 73
  • [24] Sensitization of human granulosa tumor cell lines to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Woods, Dori
    Johnson, Alan
    BIOLOGY OF REPRODUCTION, 2007, : 213 - 213
  • [25] Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptor Expression in Patients with Neuroendocrine Neoplasia
    Saettele, R.
    Jann, H.
    Fischer, C.
    Pape, U. F.
    Schefold, J. C.
    Koschny, R.
    Pschowski, R.
    NEUROENDOCRINOLOGY, 2018, 106 : 17 - 17
  • [26] Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
    Kamohara, H
    Matsuyama, W
    Shimozato, O
    Abe, K
    Galligan, C
    Hashimoto, SI
    Matsushima, K
    Yoshimura, T
    IMMUNOLOGY, 2004, 111 (02) : 186 - 194
  • [27] Bortezomib sensitizes human astrocytoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
    Kyritsis, Athanassios P.
    Tachmazoglou, Fanny
    Rao, Jasti S.
    Puduvalli, Vinay K.
    CLINICAL CANCER RESEARCH, 2007, 13 (21) : 6540 - 6541
  • [28] Expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in human colorectal adenocarcinomas.
    Younes, M
    Carlson, N
    All, N
    Younes, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1419 - A1419
  • [29] Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
    Nguyen, T
    Zhang, XD
    Hersey, P
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 966S - 973S
  • [30] Mechanisms of sensitivity and resistance of melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Kurbanov, B. M.
    Fecker, L. F.
    Sterry, W.
    Eberle, J.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 263 - 263
12345